Risk is almost always a product of self-sourcing unregulated vials , poor reconstitution , non-sterile technique , or wrong dose for goal - all of which we see in patients who come to us after online DIY protocols
It is important to note that, in patients with long-standing diabetes and insufficient insulin secretory capacity, the glucose-lowering efficacy of GLP-1 RA is likely to be reduced as a result of diminished incretin effects, and concomitant basal insulin treatment may be required [53]
What are amylin receptor agonists The science behind synthetic amylin peptides
If you are tapering off a GLP-1 or already have, that gives you and your clinician a concrete view of one biological factor in play, rather than a vague sense that your body is working against you
Growth hormone secretagogues are substances that stimulate your body to produce its own growth hormone rather than replace it, unlike synthetic growth hormone